Dynavax Technologies Corp DVAX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/18/22 EDT
9.70quote price arrow up+0.08 (+0.83%)
Volume
151,409
Close
9.62quote price arrow down-0.11 (-1.13%)
Volume
4,381,960
52 week range
7.26 - 21.39
Loading...
  • Open9.40
  • Day High9.66
  • Day Low9.27
  • Prev Close9.62
  • 52 Week High21.39
  • 52 Week High Date11/04/21
  • 52 Week Low7.26
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap1.215B
  • Shares Out126.31M
  • 10 Day Average Volume6.83M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • YTD % Change-31.63

KEY STATS

  • Open9.40
  • Day High9.66
  • Day Low9.27
  • Prev Close9.62
  • 52 Week High21.39
  • 52 Week High Date11/04/21
  • 52 Week Low7.26
  • 52 Week Low Date05/12/22
  • Market Cap1.215B
  • Shares Out126.31M
  • 10 Day Average Volume6.83M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • YTD % Change-31.63

RATIOS/PROFITABILITY

  • EPS (TTM)0.52
  • P/E (TTM)18.51
  • Fwd P/E (NTM)8.20
  • EBITDA (TTM)142.023M
  • ROE (TTM)53.77%
  • Revenue (TTM)470.10M
  • Gross Margin (TTM)59.82%
  • Net Margin (TTM)23.12%
  • Debt To Equity (MRQ)76.79%

EVENTS

  • Earnings Date08/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Dynavax Technologies Corp

There is no recent news for this security.

Profile

MORE
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company that is focused on developing and commercializing vaccines. The Company's products include HEPLISAV-B and CpG 1018. The HEPLISAV-B is indicated for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults. HEPLISAV-B is a sterile solution for injection presented in 0.5 mL single-dose...
Scott Myers
Independent Chairman of the Board
Ryan Spencer
Chief Executive Officer, Director
David Novack
President, Chief Operating Officer
Kelly MacDonald CPA
Chief Financial Officer, Senior Vice President
Address
2100 POWELL STREET, SUITE 900
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
NVTA
Invitae Corp
3.44-0.36-9.47%
RGNX
Regenxbio Inc
19.57-2.13-9.82%
RCUS
Arcus Biosciences Inc
18.87-2.12-10.10%
ITOS
Iteos Therapeutics Inc
16.92-2.09-10.99%
XNCR
Xencor Inc
22.55-2.26-9.11%